Myomo
NYSE: MYOCambridge, US · Delaware corporation · 1 known investors
Myomo develops wearable robotic orthoses to restore arm and hand function for individuals with limited mobility due to stroke, brachial plexus injury, or spinal cord injury. The company serves patients and healthcare providers in the medical device and rehabilitation markets.
Founders & leadership
PR
Paul R. GudonisinChairman & Chief Executive Officer
SK
Steve KellyNamed on SEC filing
Board
TK
Thomas KirkBoard director
BS
Byron SmithBoard director
TA
Thomas A. Crowley, Jr.Board director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 3 rounds · 2014–2016
▶$200KraisedJul 2016 · 2 investors · Other Health CareRule 506(b)
▶$200KraisedJul 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Byron SmithDirector
- Davie MendelsohnExecutive Officer
- Thomas KirkDirector
- Steve KellyExecutive Officer, Director
- Paul GudonisExecutive Officer, Director
- Jonathan NaftExecutive Officer
- Thomas A. Crowley, Jr.Director
- Offering amount
- $3M
- Amount sold
- $200K
- Placement agents
- Healthios Capital Markets, LLC, Tripoint Global Equities, LLC
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$620KraisedJan 2016 · 6 investors · Other Health CareRule 506(b)
▶$620KraisedJan 2016 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas KirkDirector
- Byron SmithDirector
- Paul GudonisExecutive Officer, Director
- Thomas A. Crowley, Jr.Director
- Steve KellyExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $620K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedAug 2014 · 37 investors · Other Health CareRule 506(b)
▶$1.7MraisedAug 2014 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steve KellyExecutive Officer, Director
- Paul GudonisExecutive Officer, Director
- Byron SmithDirector
- Thomas A. Crowley, Jr.Director
- Offering amount
- $5.3M
- Amount sold
- $1.7M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Neurolutions40 shared keywordsNeurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness. The system pairs a non-invasive EEG headset, a thought-controlled wireless handpiece, and a tablet to guide and track therapy.
Ispot Tv32 shared keywordsiSpot is an advertising technology platform that provides TV ad analytics and intelligence for media companies and advertisers.
Companies competing with Myomo for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $144.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - BioSpacebiospace.com · Sep 2026Frequently asked questions
- What does Myomo do?
- Myomo develops wearable robotic orthoses to restore arm and hand function for individuals with limited mobility due to stroke, brachial plexus injury, or spinal cord injury. The company serves patients and healthcare providers in the medical device and rehabilitation markets.
- Who are Myomo's investors?
- Myomo's investors include Boston Harbor Angels.
- How much funding has Myomo raised?
- Myomo has disclosed $2.5M raised across 3 rounds.
- Where is Myomo headquartered?
- Myomo is headquartered in Cambridge, US.